Kai Chen

Shantou University

H指数:11

被引数:906

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Dickkopf Protein Family in Non-Neoplastic Disorders: Emerging Roles and Therapeutic Targeting

Dickkopf蛋白家族在非肿瘤性疾病中的新兴作用及靶向治疗

Aging and Disease

IF6.9

2026-05-010

PRE

Recent Advancements of Neoadjuvant Strategies in Locally Advanced Rectal Cancer

局部晚期直肠癌新辅助治疗的最新进展

Critical Reviews in Oncology/Hematology

IF0

2026-03-310

PRE

Multi-Omics Analysis of Ketogenic Diet-Mediated Neural Repair in Spinal Cord Injury: Targeting of Lysosomal Autophagy through CTSB/LAMP2 Regulation

ketogenic diet-mediated neural repair in spinal cord injury: targeting of lysosomal autophagy through CTSB/LAMP2 regulation

The Journal of Nutritional Biochemistry

IF0

2025-10-200

PRE

Identification of FLVCR1 as the iron metabolism-related gene of statin-associated diabetes

ACTA DIABETOLOGICA

IF2.9

2025-03-010

PRE

miR-223 accelerates lipid droplets clearance in microglia following spinal cord injury by upregulating ABCA1

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2024-07-151

OAAI

Dynamic evolution of bone marrow adipocyte in B cell acute lymphoblastic leukemia: insights from diagnosis to post-chemotherapy

CANCER BIOLOGY & THERAPY

IF4.6

2024-03-111

OAAI

Mannose ameliorates experimental colitis by protecting intestinal barrier integrity

NATURE COMMUNICATIONS

IF15.7

2022-08-16101

OAAI

Establishment and Validation of a Novel MRI Radiomics Feature-Based Prognostic Model to Predict Distant Metastasis in Endemic Nasopharyngeal Carcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2022-03-235

OAAI

Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma

CELL DEATH DISCOVERY

IF7

2022-01-288

OAAI

Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulation

辛伐他汀主要通过PI3K/AKT通路减弱和Myc下调增强伊马替尼对伊马替尼耐药的慢性粒细胞白血病细胞的细胞杀伤活性

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2021-12-017

PRE

Preclinical evaluation of a regimen combining chidamide and ABT-199 in acute myeloid leukemia

CELL DEATH & DISEASE

IF9.6

2020-09-1828

OAAI

Synthetic lethality of combined AT-101 with idarubicin in acute myeloid leukemia via blockade of DNA repair and activation of intrinsic apoptotic pathway

CANCER LETTERS

IF10.1

2019-10-0112

PREAI

Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2019-07-0118

PREAI

Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE-/- mice

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2019-05-0185

OAAI

Paeoniflorin improves pressure overload-induced cardiac remodeling by modulating the MAPK signaling pathway in spontaneously hypertensive rats

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2019-03-0151

OAAI

Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells

CLINICAL EPIGENETICS

IF4.4

2017-08-1454

OAAI

The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells

TARGETED ONCOLOGY

IF4

2017-07-1414

PREAI

Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-kB and Nrf2

CELL DEATH & DISEASE

IF9.6

2017-05-18117

OAAI

Kai Chen

个人简介

教育背景

工作经历

荣誉奖项

研究方向